Pfanstiel Steven — SEC Form 4 filings
SEC reporting owner CIK 1856059. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-19 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 32,749 shares, $69,590 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 3,092 shares @ $9.97 ($30,827) in MARINUS PHARMACEUTICALS, INC., filed 2024-02-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) | CFO AND COO | 5 | — | 2 legs · 7,749 sh · $36,090 | 11 |
| Neuronetics, Inc. (STIM) | Former EVP, CFO and Treasurer | 6 | — | 2 legs · 25,000 sh · $33,500 | 5 |
Form 4 filings — Pfanstiel Steven
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4/A | Neuronetics, Inc. (STIM) | Sale (S): 8,569 @ $1.34 | EDGAR |
| 2026-03-24 | 4 | Neuronetics, Inc. (STIM) | Sale (S): 16,431 @ $1.34 | EDGAR |
| 2026-03-18 | 4 | Neuronetics, Inc. (STIM) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-02-25 | 4 | Neuronetics, Inc. (STIM) | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2025-12-31 | 4 | Neuronetics, Inc. (STIM) | Grant/award (A): 170,212 @ $0 | EDGAR |
| 2025-07-15 | 4 | Neuronetics, Inc. (STIM) | Grant/award (A): 200,000 @ $0 · Grant/award (A): 200,000 @ $0 | EDGAR |
| 2025-02-11 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Disposition to issuer (D): 17,303 @ $0.55 · Disposition to issuer (D): 62,470 @ $0.55 · Disposition to issuer (D): 57,300 (derivative) @ $0 · Disposition to issuer (D): 114,600 (derivative) @ $0 · Disposition to issuer (D): 126,585 (derivative) @ $0 · Disposition to issuer (D): 74,475 (derivative) @ $0 · +1 more | EDGAR |
| 2024-08-07 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale (S): 4,657 @ $1.13 | EDGAR |
| 2024-06-20 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 12,733 @ $0 · Grant/award (A): 57,300 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale (S): 3,092 @ $9.97 | EDGAR |
| 2024-01-19 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 25,465 @ $0 · Grant/award (A): 114,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856059 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →